Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma

SIMPLE SUMMARY: The activity of novel therapies that utilize patient’s own T-cells to induce remission of B-cell non-Hodgkin lymphoma (B-NHL), including chronic lymphocytic leukemia (CLL), is still suboptimal. In this review, we summarize the clinical efficacy of T-cell-based therapies in B-NHL and...

Descripción completa

Detalles Bibliográficos
Autores principales: van Bruggen, Jaco A. C., Martens, Anne W. J., Tonino, Sanne H., Kater, Arnon P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765898/
https://www.ncbi.nlm.nih.gov/pubmed/33353234
http://dx.doi.org/10.3390/cancers12123837

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765898/
https://www.ncbi.nlm.nih.gov/pubmed/33353234
http://dx.doi.org/10.3390/cancers12123837

Ejemplares similares